Therapeutic Application of Adipose Derived Stem Cells in Acute Myocardial Infarction: Lessons from Animal Models

Stem Cell Reviews and Reports

Volumn 10, Issue 3, 2014, Pages 389-398

  Naaijkens, B A ^a,b,c   van Dijk, A ^a,b   Kamp, O ^a,b,c   Krijnen, P A J ^a,b   Niessen, H W M ^a,b   Juffermans, L J M ^a,b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Acute myocardial infarction; Adipose derived stem cells; Animal models; Cellular therapy

Indexed keywords

ADIPOSE TISSUE; ANIMAL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MYOCARDIAL INFARCTION; PHYSIOLOGY; PROCEDURES;

ADIPOSE TISSUE; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION;

EID: 84899972223     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-014-9502-7     Document Type: Article

References (67)

1. Shah, V. K., & Shalia, K. K. (2011). Stem cell therapy in acute myocardial infarction: a pot of gold or Pandora's Box. Stem Cells International, 2011, 536758.
2. Kuraitis, D., Ruel, M., & Suuronen, E. J. (2011). Mesenchymal stem cells for cardiovascular regeneration. Cardiovascular Drugs and Therapy, 25(4), 349-362.
3. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., et al. (2012). Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation, 125(1), 188-197.
4. Pfeffer, M. A., & Braunwald, E. (1990). Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation, 81(4), 1161-1172.
5. Friedenstein, A. J., Deriglasova, U. F., Kulagina, N. N., et al. (1974). Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Experimental Hematology, 2(2), 83-92.
6. Zuk, P. A., Zhu, M., Ashjian, P., et al. (2002). Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 13(12), 4279-4295.
7. Naaijkens, B. A., Niessen, H. W., Prins, H. J., et al. (2012). Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Cell and Tissue Research, 348(1), 119-130.
8. Boyle, A. J., McNiece, I. K., & Hare, J. M. (2010). Mesenchymal stem cell therapy for cardiac repair. Methods in Molecular Biology, 660, 65-84.
9. Oswald, J., Boxberger, S., Jorgensen, B., et al. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells, 22(3), 377-384.
10. Pittenger, M. F., & Martin, B. J. (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circulation Research, 95(1), 9-20.
11. Psaltis, P. J., Zannettino, A. C., Worthley, S. G., & Gronthos, S. (2008). Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells, 26(9), 2201-2210.
12. Katz, A. J., Tholpady, A., Tholpady, S. S., Shang, H., & Ogle, R. C. (2005). Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells, 23(3), 412-423.
13. Nakagami, H., Morishita, R., Maeda, K., Kikuchi, Y., Ogihara, T., & Kaneda, Y. (2006). Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. Journal of Atherosclerosis and Thrombosis, 13(2), 77-81.
14. Varma, M. J., Breuls, R. G., Schouten, T. E., et al. (2007). Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells and Development, 16(1), 91-104.
15. Rasmussen, J. G., Frobert, O., Holst-Hansen, C., et al. (2012). Comparison of human adipose-derived stem cells and bone marrow-derived stem cells in a myocardial infarction model. Cell Transplantation (Epub ahead of print).
16. Paul, A., Srivastava, S., Chen, G., Shum-Tim, D., & Prakash, S. (2013). Functional assessment of adipose stem cells for xenotransplantation using myocardial infarction immunocompetent models: comparison with bone marrow stem cells. Cell Biochemistry and Biophysics, 67(2), 263-273.
17. Yamada, Y., Wang, X. D., Yokoyama, S., Fukuda, N., & Takakura, N. (2006). Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium. Biochemical and Biophysical Research Communications, 342(2), 662-670.
18. Bayes-Genis, A., Soler-Botija, C., Farre, J., et al. (2010). Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. Journal of Molecular and Cellular Cardiology, 49(5), 771-780.
19. Bai, X., Yan, Y., Song, Y. H., et al. (2010). Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. European Heart Journal, 31(4), 489-501.
20. Gaebel, R., Furlani, D., Sorg, H., et al. (2011). Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS One, 6(2), e15652.
21. Li, T. S., Cheng, K., Malliaras, K., et al. (2012). Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. Journal of the American College of Cardiology, 59(10), 942-953.
22. Kim, S. W., Lee, D. W., Yu, L. H., et al. (2012). Mesenchymal stem cells overexpressing GCP-2 improve cardiac function through enhanced angiogenic properties in a myocardial infarction model. Cardiovascular Research, 95(4), 495-506.
23. Cai, L., Johnstone, B. H., Cook, T. G., et al. (2009). IFATS collection: human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells, 27(1), 230-237.
24. Ii, M., Horii, M., Yokoyama, A., et al. (2011). Synergistic effect of adipose-derived stem cell therapy and bone marrow progenitor recruitment in ischemic heart. Laboratory Investigation, 91(4), 539-552.
25. Hong, S. J., Kihlken, J., Choi, S. C., March, K. L., & Lim, D. S. (2013). Intramyocardial transplantation of human adipose-derived stromal cell and endothelial progenitor cell mixture was not superior to individual cell type transplantation in improving left ventricular function in rats with myocardial infarction. International Journal of Cardiology, 164(2), 205-211.
26. Beitnes, J. O., Oie, E., Shahdadfar, A., et al. (2012). Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function. Cell Transplantation, 21(8), 1697-1709.
27. van der Bogt, K. E., Schrepfer, S., Yu, J., et al. (2009). Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation, 87(5), 642-652.
28. Leobon, B., Roncalli, J., Joffre, C., et al. (2009). Adipose-derived cardiomyogenic cells: in vitro expansion and functional improvement in a mouse model of myocardial infarction. Cardiovascular Research, 83(4), 757-767.
29. Yu, L. H., Kim, M. H., Park, T. H., et al. (2010). Improvement of cardiac function and remodeling by transplanting adipose tissue-derived stromal cells into a mouse model of acute myocardial infarction. International Journal of Cardiology, 139(2), 166-172.
30. Tokunaga, M., Liu, M. L., Nagai, T., et al. (2010). Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction. Journal of Molecular and Cellular Cardiology, 49(6), 972-983.
31. Hoke, N. N., Salloum, F. N., Kass, D. A., Das, A., & Kukreja, R. C. (2012). Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice. Stem Cells, 30(2), 326-335.
32. Zhang, Z., Li, S., Cui, M., et al. (2013). Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways. Basic Research in Cardiology, 108(2), 333-0333.
33. Li, B., Zeng, Q., Wang, H., et al. (2007). Adipose tissue stromal cells transplantation in rats of acute myocardial infarction. Coronary Artery Disease, 18(3), 221-227.
34. Schenke-Layland, K., Strem, B. M., Jordan, M. C., et al. (2009). Adipose tissue-derived cells improve cardiac function following myocardial infarction. Journal of Surgical Research, 153(2), 217-223.
35. Shi, C. Z., Zhang, X. P., Lv, Z. W., et al. (2012). Adipose tissue-derived stem cells embedded with eNOS restore cardiac function in acute myocardial infarction model. International Journal of Cardiology, 154(1), 2-8.
36. Paul, A., Nayan, M., Khan, A. A., Shum-Tim, D., & Prakash, S. (2012). Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction. International Journal of Nanomedicine, 7, 663-682.
37. Liu, Z., Wang, H., Wang, Y., et al. (2012). The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials, 33(11), 3093-3106.
38. Carvalho, J. L., Braga, V. B., Melo, M. B., et al. (2013). Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction. Journal of Cellular and Molecular Medicine, 17(5), 617-625.
39. Danoviz, M. E., Nakamuta, J. S., Marques, F. L., et al. (2010). Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention. PLoS One, 5(8), e12077.
40. Zhu, X. Y., Zhang, X. Z., Xu, L., Zhong, X. Y., Ding, Q., & Chen, Y. X. (2009). Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue. Biochemical and Biophysical Research Communications, 379(4), 1084-1090.
41. van Dijk, A., Naaijkens, B. A., Jurgens, W. J. F. M., et al. (2011). Reduction of infarct size by intravenous injection of uncultured adipose derived stromal cells in a rat model is dependent on the time point of application. Stem Cell Research, 7(3), 219-229.
42. Wang, L., Deng, J., Tian, W., et al. (2009). Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. American Journal of Physiology - Heart and Circulatory Physiology, 297(3), H1020-H1031.
43. Hwangbo, S., Kim, J., Her, S., Cho, H., & Lee, J. (2010). Therapeutic potential of human adipose stem cells in a rat myocardial infarction model. Yonsei Medical Journal, 51(1), 69-76.
44. Zhang, X., Wang, H., Ma, X., et al. (2010). Preservation of the cardiac function in infarcted rat hearts by the transplantation of adipose-derived stem cells with injectable fibrin scaffolds. Experimental Biology and Medicine (Maywood, N. J.), 235(12), 1505-1515.
45. Berardi, G. R., Rebelatto, C. K., Tavares, H. F., et al. (2011). Transplantation of SNAP-treated adipose tissue-derived stem cells improves cardiac function and induces neovascularization after myocardium infarct in rats. Experimental and Molecular Pathology, 90(2), 149-156.
46. Karpov, A. A., Uspenskaya, Y. K., Minasian, S. M., et al. (2013). The effect of bone marrow- and adipose tissue-derived mesenchymal stem cell transplantation on myocardial remodelling in the rat model of ischaemic heart failure. International Journal of Experimental Pathology, 94(3), 169-177.
47. Yang, J. J., Yang, X., Liu, Z. Q., et al. (2012). Transplantation of adipose tissue-derived stem cells overexpressing heme oxygenase-1 improves functions and remodeling of infarcted myocardium in rabbits. Tohoku Journal of Experimental Medicine, 226(3), 231-241.
48. Alt, E., Pinkernell, K., Scharlau, M., et al. (2010). Effect of freshly isolated autologous tissue resident stromal cells on cardiac function and perfusion following acute myocardial infarction. International Journal of Cardiology, 144(1), 26-35.
49. Valina, C., Pinkernell, K., Song, Y. H., et al. (2007). Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. European Heart Journal, 28(21), 2667-2677.
50. De, S. R., Balducci, L., Blasi, A., et al. (2010). Omentum-derived stromal cells improve myocardial regeneration in pig post-infarcted heart through a potent paracrine mechanism. Experimental Cell Research, 316(11), 1804-1815.
51. Rigol, M., Solanes, N., Farre, J., et al. (2010). Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration. Journal of Cardiac Failure, 16(4), 357-366.
52. Mazo, M., Hernandez, S., Gavira, J. J., et al. (2012). Treatment of reperfused ischemia with adipose-derived stem cells in a preclinical swine model of myocardial infarction. Cell Transplantation, 21(12), 2723-2733.
53. Bosma, M. J., & Carroll, A. M. (1991). The SCID mouse mutant: definition, characterization, and potential uses. Annual Review of Immunology, 9, 323-350.
54. Cook, J. L., Ikle, D. N., & Routes, B. A. (1995). Natural killer cell ontogeny in the athymic rat. Relationship between functional maturation and acquired resistance to E1A oncogene-expressing sarcoma cells. Journal of Immunology, 155(12), 5512-5518.
55. Bodi, V., Sanchis, J., Nunez, J., et al. (2008). Uncontrolled immune response in acute myocardial infarction: unraveling the thread. American Heart Journal, 156(6), 1065-1073.
56. Wang, Q. D., & Sjoquist, P. O. (2006). Myocardial regeneration with stem cells: pharmacological possibilities for efficacy enhancement. Pharmacological Research, 53(4), 331-340.
57. Malek, S., Kaplan, E., Wang, J. F., et al. (2006). Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis. Pflügers Archiv, 452(3), 268-275.
58. Zaragoza, C., Gomez-Guerrero, C., Martin-Ventura, J. L., et al. (2011). Animal models of cardiovascular diseases. Journal of Biomedicine and Biotechnology, 2011, 497841.
59. Jennings, R., Sommers, H., Smyth, G., Flack, H., & Linn, H. (1960). Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Archives of Pathology, 70, 68-78.
60. Yellon, D. M., & Hausenloy, D. J. (2007). Myocardial reperfusion injury. New England Journal of Medicine, 357(11), 1121-1135.
61. Krijnen, P. A., Meischl, C., Nijmeijer, R., Visser, C. A., Hack, C. E., & Niessen, H. W. (2006). Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction? Cardiovascular & Hematological Disorders Drug Targets, 6(2), 113-123.
62. Shim, W. S., Tan, G., Gu, Y., et al. (2010). Dose-dependent systolic contribution of differentiated stem cells in post-infarct ventricular function. Journal of Heart and Lung Transplantation, 29(12), 1415-1426.
63. Wolf, D., Reinhard, A., Seckinger, A., Katus, H. A., Kuecherer, H., & Hansen, A. (2009). Dose-dependent effects of intravenous allogeneic mesenchymal stem cells in the infarcted porcine heart. Stem Cells and Development, 18(2), 321-329.
64. Wei, H., Ooi, T. H., Tan, G., et al. (2010). Cell delivery and tracking in post-myocardial infarction cardiac stem cell therapy: an introduction for clinical researchers. Heart Failure Reviews, 15(1), 1-14.
65. Zhu, Y., Liu, T., Song, K., Fan, X., Ma, X., & Cui, Z. (2008). Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochemistry and Function, 26(6), 664-675.
66. Fischer, U. M., Harting, M. T., Jimenez, F., et al. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells and Development, 18(5), 683-692.
67. Houtgraaf, J. H., den Dekker, W. K., van Dalen, B. M., et al. (2012). First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 59(5), 539-540.